During the past decade, Hôpital Bretonneau - Hématologie et Thérapie Cellulaire conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hôpital Bretonneau - Hématologie et Thérapie Cellulaire" #1 collaborator was "AbbVie" with 1 trials as a collaborator, "Amgen" with 1 trials as a collaborator, "Institut de cancérologie Strasbourg Europe" with 1 trials as a collaborator, "Janssen, LP" with 1 trials as a collaborator and "Janssen-Cilag Ltd." with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Hôpital Bretonneau - Hématologie et Thérapie Cellulaire" are "Chronic Lymphocytic Leukemia, Lymphocytic Lymphoma or Waldenstrom Disease" (1 trials), "Chronic Lymphoid Leukemia" (1 trials), "Fit Patients" (1 trials), "Intermediate Risk Chronic Lymphocytic Leukemia" (1 trials) and "Relapsed or Refractory Chronic Lymphocytic Leukemia" (1 trials). Many other conditions were trialed in "Hôpital Bretonneau - Hématologie et Thérapie Cellulaire" in a lesser frequency.

Most popular intervention types in "Hôpital Bretonneau - Hématologie et Thérapie Cellulaire" are "Drug" (5 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "ACA Continuation" (1 trials), "Blinatumomab" (1 trials), "Daratumumab" (1 trials), "Data registry" (1 trials) and "FCR" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hôpital Bretonneau - Hématologie et Thérapie Cellulaire" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Hôpital Bretonneau - Hématologie et Thérapie Cellulaire". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Hôpital Bretonneau - Hématologie et Thérapie Cellulaire, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hôpital Bretonneau - Hématologie et Thérapie Cellulaire, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".